CMS Open Payments · Program Year 2024
Calvary Spine, LLC
Calvary Spine, LLC reported $703,196.00 across General Payments, Research, and Ownership to 0 physicians and teaching hospitals across 2 transactions.
- $703.2K Above-median payer
- All-tracks total
- 2 Below-median volume
- Transactions
- 0 —
- Recipients
- #693
- of 1,925 companies
Calvary Spine, LLC reported $703,196.00 across all CMS Open Payments tracks (General + Research + Ownership) to 0 physicians and teaching hospitals in Program Year 2024 - ranking #693 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total), averaging $0.00 per recipient.
Calvary Spine, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
16/100
Transaction volume
F
10/100
Physician reach and Payment type diversity not applicable for Calvary Spine, LLC - no recorded activity on that dimension; its weight was redistributed to the applicable dimensions above.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer calvary-spine-llc Calvary Spine, LLC
$703.2K · #693/1,925 · 0.0% industry · PY2024
- TOT $703.2K
- RANK #693
- SHARE 0.0%
- TXN 2
- RCP 0
- CAT 0
- GEN n/a
- PY 2024
Volume peers
Nearest volume peer: Day One Biopharmaceuticals ($703.0K)
Calvary Spine, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Calvary Spine, LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Calvary Spine, LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Calvary Spine, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
SurGenTec
Napo Pharmaceuticals Inc
Kuros Biosciences USA, Inc
Kaneka Medical America LLC
Scilex Pharmaceuticals Inc.
Put this to use
Calvary Spine, LLC ranks #693 of 1,925 by all-tracks total payments.
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare payment categories across every manufacturer. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.